about
Why do doctors and patients not follow guidelines?Levocetirizine in the treatment of allergic diseases.Emerging sublingual immunotherapy drugs.Towards the Grade of Recommendations, Assessment, Development and Evaluation system: methods and results of budesonide/formoterol maintenance and reliever therapy research.New directions in immunotherapy.Application of GRADE: making evidence-based recommendations about diagnostic tests in clinical practice guidelines.Sublingual immunotherapy for allergic rhinitis: an updateSublingual immunotherapy: other indicationsAdvances in allergen-specific immunotherapy
P50
Q37458095-7D4D32D3-E299-4A51-A4EE-D3676AC8CBF5Q37575658-B8318BC0-C116-43D8-9EEF-CEA70240DC2AQ37801372-812DB3F8-D046-4B51-8674-FC554DD2C3FBQ37887434-FCA316B0-5A82-4AAE-8649-95A7A1095F67Q38073718-C73ADEAE-AC4E-49C0-8205-386AF0E6CC04Q42780560-EC77648E-8891-41C8-A117-DB16FCA59208Q82576152-81D3F379-408A-4EB4-BEBA-13F948FFFCE2Q84003283-3A0E013A-6E5E-426B-8506-BFEE26C536A5Q84892072-93B5D4C6-0B38-49E7-B75C-910D93F00D13
P50
description
researcher ORCID ID = 0000-0002-1856-6139
@en
name
Enrico Compalati
@ast
Enrico Compalati
@en
Enrico Compalati
@es
Enrico Compalati
@nl
type
label
Enrico Compalati
@ast
Enrico Compalati
@en
Enrico Compalati
@es
Enrico Compalati
@nl
prefLabel
Enrico Compalati
@ast
Enrico Compalati
@en
Enrico Compalati
@es
Enrico Compalati
@nl
P21
P31
P496
0000-0002-1856-6139